Zydus Lifesciences, 532321, ZYDUSLIFE Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,09,875.05
21.80
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,20,227.95
0.09%
4.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.44
10.04
10.48

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.46
15.28
14.05

PAT CAGR (%)

10 Years
5 Years
3 Years

8.98
15.71
33.68

P:E (Median)

8 Years
5 Years
3 Years

21.86
22.15
22.77

P:BV (Average)

8 Years
5 Years
3 Years

3.60
3.66
4.19

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.06
14.34
14.59

Earnings Forecasts:

(Updated: 27-06-2026)

Description 2026 2027 2028 2029
Adj EPS 4.61 45.44 42.47 49.72
P/E Ratio 238.92 24.24 25.93 22.15
Revenue 20.97 26488.3 30566.4 34036.5
EBITDA 36893.8 7084.39 7470.68 8481.88
Net Income 8748.44 4610.69 4283.35 5013.35
ROA 5349.58 11.72 8.42 9.09
P/B Ratio 0.27 3.96 3.59 3.16
ROE 2.83 17.44 14.49 14.73
FCFF 13.75 -834.79 3497.19 4298.7
FCFF Yield 4729.76 -0.71 2.99 3.67
Net Debt 4.04 211.89 3495.26 1367.54
BVPS 4097.93 277.87 306.94 348.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 3,740.90 5,819.60 -35.72% 2,283.60 2,515.90 -9.23% 2,871.20 2,620.60 9.56% 2,588.30 4,160.20 -37.78%
Expenses 2,399.70 2,046.90 17.24% 2,084.60 1,867.40 11.63% 2,115.10 1,733.00 22.05% 2,002.90 1,787.30 12.06%
EBITDA 1,341.20 3,772.70 -64.45% 199.00 648.50 -69.31% 756.10 887.60 -14.82% 585.40 2,372.90 -75.33%
EBIDTM 35.85% 64.83% 8.71% 25.78% 26.33% 33.87% 22.62% 57.04%
Other Income 1,143.00 185.40 516.50% 473.80 77.50 511.35% 937.30 381.30 145.82% 157.10 106.60 47.37%
Interest 115.50 155.40 -25.68% 116.00 97.20 19.34% 113.80 95.90 18.67% 137.60 115.40 19.24%
Depreciation 150.90 128.00 17.89% 144.30 131.60 9.65% 136.00 133.70 1.72% 130.00 130.60 -0.46%
PBT 2,111.00 3,674.70 -42.55% 352.40 497.20 -29.12% 1,443.60 1,039.30 38.90% 474.90 2,233.50 -78.74%
Tax 389.00 861.00 -54.82% 55.90 26.60 110.15% 287.00 249.50 15.03% 90.20 532.70 -83.07%
PAT 1,722.00 2,813.70 -38.80% 296.50 470.60 -37.00% 1,156.60 789.80 46.44% 384.70 1,700.80 -77.38%
PATM 46.03% 48.35% 12.98% 18.70% 40.28% 30.14% 14.86% 40.88%
EPS 17.11 27.96 -38.81% 2.95 4.68 -36.97% 11.49 7.85 46.37% 3.82 16.90 -77.40%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 7,587.00 6,527.90 16.22% 6,864.50 5,269.10 30.28% 6,123.20 5,237.00 16.92% 6,573.70 6,207.50 5.90%
Expenses 5,677.50 4,402.40 28.96% 5,048.10 3,881.50 30.06% 4,521.50 3,821.00 18.33% 4,542.30 4,123.50 10.16%
EBITDA 1,909.50 2,125.50 -10.16% 1,816.40 1,387.60 30.90% 1,601.70 1,416.00 13.11% 2,031.40 2,084.00 -2.52%
EBIDTM 25.17% 32.56% 26.46% 26.33% 26.16% 27.04% 30.90% 33.57%
Other Income 779.10 80.60 866.63% 111.40 57.50 93.74% 523.10 113.60 360.48% 212.00 63.20 235.44%
Interest 123.00 76.60 60.57% 129.90 32.00 305.94% 101.30 25.10 303.59% 84.70 32.20 163.04%
Depreciation 508.40 237.90 113.70% 359.60 229.00 57.03% 301.90 233.60 29.24% 238.10 215.30 10.59%
PBT 1,659.70 1,672.00 -0.74% 1,353.40 1,184.10 14.30% 1,687.40 1,270.90 32.77% 1,920.60 1,899.70 1.10%
Tax 318.40 423.20 -24.76% 388.30 179.50 116.32% 454.00 373.10 21.68% 434.00 436.10 -0.48%
PAT 1,341.30 1,248.80 7.41% 965.10 1,004.60 -3.93% 1,233.40 897.80 37.38% 1,486.60 1,463.60 1.57%
PATM 17.68% 19.13% 14.06% 19.07% 20.14% 17.14% 22.61% 23.58%
EPS 12.65 11.64 8.68% 10.36 10.17 1.87% 12.51 9.06 38.08% 14.58 14.11 3.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 11,484.00 15,116.30 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40 6,037.40 5,809.90 3,230.70 7,032.00 Net Sales Growth -24.03% 39.72% 23.90% 11.42% 0.73% 22.57% 5.13% 3.92% 79.83% -54.06% Cost Of Goods Sold 3,576.80 2,454.20 2,589.90 2,597.40 2,467.20 1,993.20 1,656.30 1,548.50 1,398.90 841.10 1,574.40 Gross Profit 7,907.20 12,662.10 8,228.80 6,134.20 5,369.70 5,786.80 4,691.10 4,488.90 4,411.00 2,389.60 5,457.60 GP Margin 68.85% 83.76% 76.06% 70.25% 68.52% 74.38% 73.91% 74.35% 75.92% 73.97% 77.61% Total Expenditure 8,602.30 7,589.60 6,838.10 6,553.20 6,065.50 5,472.60 4,927.50 4,412.70 4,163.60 2,909.60 4,456.40 Power & Fuel Cost - 269.80 280.60 261.30 230.30 178.60 193.30 185.80 157.10 119.60 126.70 % Of Sales - 1.78% 2.59% 2.99% 2.94% 2.30% 3.05% 3.08% 2.70% 3.70% 1.80% Employee Cost - 1,453.90 1,215.70 1,055.30 976.40 928.70 872.40 776.00 655.00 620.80 585.30 % Of Sales - 9.62% 11.24% 12.09% 12.46% 11.94% 13.74% 12.85% 11.27% 19.22% 8.32% Manufacturing Exp. - 2,062.00 1,719.50 1,637.00 1,472.80 1,493.00 1,355.10 1,273.20 1,190.20 625.40 1,148.70 % Of Sales - 13.64% 15.89% 18.75% 18.79% 19.19% 21.35% 21.09% 20.49% 19.36% 16.34% General & Admin Exp. - 316.70 247.10 281.60 167.00 146.00 208.20 162.20 191.50 237.20 170.20 % Of Sales - 2.10% 2.28% 3.23% 2.13% 1.88% 3.28% 2.69% 3.30% 7.34% 2.42% Selling & Distn. Exp. - 682.30 483.20 456.40 475.80 441.30 362.60 294.60 314.10 214.50 647.50 % Of Sales - 4.51% 4.47% 5.23% 6.07% 5.67% 5.71% 4.88% 5.41% 6.64% 9.21% Miscellaneous Exp. - 350.70 302.10 264.20 276.00 291.80 279.60 172.40 256.80 251.00 647.50 % Of Sales - 2.32% 2.79% 3.03% 3.52% 3.75% 4.40% 2.86% 4.42% 7.77% 2.90% EBITDA 2,881.70 7,526.70 3,980.60 2,178.40 1,771.40 2,307.40 1,419.90 1,624.70 1,646.30 321.10 2,575.60 EBITDA Margin 25.09% 49.79% 36.79% 24.95% 22.60% 29.66% 22.37% 26.91% 28.34% 9.94% 36.63% Other Income 2,711.20 930.90 1,162.90 824.40 325.40 90.60 852.60 566.50 207.90 598.90 175.90 Interest 482.90 489.00 390.70 278.20 134.90 70.90 233.90 91.70 63.90 26.90 26.50 Depreciation 561.20 523.90 504.40 488.60 478.70 451.10 428.90 358.20 293.10 250.90 221.20 PBT 4,381.90 7,444.70 4,248.40 2,236.00 1,483.20 1,876.00 1,609.70 1,741.30 1,497.20 642.20 2,503.80 Tax 822.10 1,669.80 798.30 503.00 306.00 212.30 204.10 301.50 406.40 -19.70 466.30 Tax Rate 18.76% 22.43% 18.83% 24.75% 26.29% 12.57% 13.10% 17.31% 27.14% -3.07% 18.62% PAT 3,559.80 5,774.90 3,441.50 1,529.20 857.90 1,476.20 1,353.60 1,439.80 1,090.80 661.90 2,037.50 PAT before Minority Interest 3,559.80 5,774.90 3,441.50 1,529.20 857.90 1,476.20 1,353.60 1,439.80 1,090.80 661.90 2,037.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 31.00% 38.20% 31.81% 17.51% 10.95% 18.97% 21.33% 23.85% 18.77% 20.49% 28.97% PAT Growth -38.36% 67.80% 125.05% 78.25% -41.88% 9.06% -5.99% 31.99% 64.80% -67.51% EPS 35.38 57.39 34.20 15.20 8.53 14.67 13.45 14.31 10.84 6.58 20.25

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 27,148.40 23,241.50 19,547.40 17,237.40 15,109.90 14,403.50 14,253.10 13,165.60 11,904.90 9,376.50 9,426.80 Net Sales Growth 16.81% 18.90% 13.40% 14.08% 4.90% 1.06% 8.26% 10.59% 26.97% -0.53% Cost Of Goods Sold 7,292.60 5,345.40 5,260.10 5,335.70 4,757.00 4,094.20 4,243.30 4,141.30 3,656.90 3,065.00 2,673.20 Gross Profit 19,855.80 17,896.10 14,287.30 11,901.70 10,352.90 10,309.30 10,009.80 9,024.30 8,248.00 6,311.50 6,753.60 GP Margin 73.14% 77.00% 73.09% 69.05% 68.52% 71.57% 70.23% 68.54% 69.28% 67.31% 71.64% Total Expenditure 19,789.40 16,348.00 14,248.40 13,665.50 11,935.20 11,018.20 11,472.90 10,187.20 9,057.50 7,472.30 7,097.30 Power & Fuel Cost - 358.20 366.30 343.50 299.30 231.60 252.90 231.60 211.40 174.50 155.40 % Of Sales - 1.54% 1.87% 1.99% 1.98% 1.61% 1.77% 1.76% 1.78% 1.86% 1.65% Employee Cost - 3,289.70 2,789.00 2,456.40 2,177.70 2,069.50 2,169.80 1,903.20 1,644.70 1,485.20 1,119.00 % Of Sales - 14.15% 14.27% 14.25% 14.41% 14.37% 15.22% 14.46% 13.82% 15.84% 11.87% Manufacturing Exp. - 3,445.60 2,758.10 2,639.80 2,272.30 2,271.40 2,230.00 1,923.20 1,680.40 955.30 1,397.60 % Of Sales - 14.83% 14.11% 15.31% 15.04% 15.77% 15.65% 14.61% 14.12% 10.19% 14.83% General & Admin Exp. - 933.50 625.00 620.30 506.70 357.90 582.60 462.60 398.70 466.00 356.40 % Of Sales - 4.02% 3.20% 3.60% 3.35% 2.48% 4.09% 3.51% 3.35% 4.97% 3.78% Selling & Distn. Exp. - 2,362.20 1,800.10 1,674.60 1,373.30 1,444.70 1,468.40 1,154.10 1,129.40 916.80 1,078.30 % Of Sales - 10.16% 9.21% 9.71% 9.09% 10.03% 10.30% 8.77% 9.49% 9.78% 11.44% Miscellaneous Exp. - 613.40 649.80 595.20 548.90 548.90 525.90 371.20 336.00 409.50 1,078.30 % Of Sales - 2.64% 3.32% 3.45% 3.63% 3.81% 3.69% 2.82% 2.82% 4.37% 3.37% EBITDA 7,359.00 6,893.50 5,299.00 3,571.90 3,174.70 3,385.30 2,780.20 2,978.40 2,847.40 1,904.20 2,329.50 EBITDA Margin 27.11% 29.66% 27.11% 20.72% 21.01% 23.50% 19.51% 22.62% 23.92% 20.31% 24.71% Other Income 1,625.60 459.60 369.40 474.60 390.70 75.00 117.10 208.50 133.00 147.10 116.60 Interest 438.90 191.00 81.20 129.90 127.00 186.40 341.80 195.80 110.80 63.10 52.80 Depreciation 1,408.00 915.80 764.10 722.70 713.00 669.60 696.50 598.60 538.80 373.30 292.10 PBT 6,621.10 6,246.30 4,823.10 3,193.90 2,725.40 2,604.30 1,859.00 2,392.50 2,330.80 1,614.90 2,101.20 Tax 1,594.70 1,411.90 977.50 587.80 511.70 193.60 319.80 530.30 564.40 128.90 177.40 Tax Rate 24.09% 23.43% 20.33% 22.70% 18.03% 8.07% 21.39% 22.26% 24.21% 7.98% 8.45% PAT 5,026.40 4,467.70 3,718.10 1,870.30 2,195.40 2,154.20 1,147.80 1,801.90 1,731.80 1,456.60 1,890.90 PAT before Minority Interest 4,942.90 4,614.80 3,831.40 2,001.90 2,326.40 2,205.60 1,175.60 1,851.80 1,766.40 1,485.70 1,921.30 Minority Interest -83.50 -147.10 -113.30 -131.60 -131.00 -51.40 -27.80 -49.90 -34.60 -29.10 -30.40 PAT Margin 18.51% 19.22% 19.02% 10.85% 14.53% 14.96% 8.05% 13.69% 14.55% 15.53% 20.06% PAT Growth 8.92% 20.16% 98.80% -14.81% 1.91% 87.68% -36.30% 4.05% 18.89% -22.97% EPS 49.95 44.40 36.95 18.59 21.82 21.41 11.41 17.91 17.21 14.48 18.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 21,190.10 15,716.50 13,639.40 13,240.50 12,744.50 11,260.20 8,569.20 7,745.50 6,618.30 6,276.20 Share Capital 100.60 100.60 101.20 102.40 102.40 102.40 102.40 102.40 102.40 102.40 Total Reserves 21,089.50 15,615.90 13,538.20 13,138.10 12,642.10 11,157.80 8,466.80 7,643.10 6,515.90 6,173.80 Non-Current Liabilities 4,775.90 7,387.90 5,395.30 1,786.80 2,178.50 2,942.60 3,385.90 2,401.80 2,183.10 1,053.80 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 88.10 43.40 86.50 159.40 Unsecured Loans 2,862.10 5,555.40 3,771.00 126.40 609.50 1,511.00 1,936.80 1,307.70 1,152.90 270.60 Long Term Provisions 1,737.40 1,746.10 1,408.30 1,491.60 1,448.90 1,221.30 1,195.10 848.40 830.00 425.30 Current Liabilities 11,071.10 4,392.00 4,051.20 4,898.10 5,163.50 3,952.70 3,119.20 3,101.90 3,030.70 2,324.30 Trade Payables 1,231.60 1,111.80 1,043.20 1,065.20 1,126.00 862.70 701.00 802.90 996.10 899.90 Other Current Liabilities 3,096.00 558.70 578.50 826.10 888.10 1,072.70 697.40 634.90 442.40 362.90 Short Term Borrowings 3,019.50 618.10 969.30 2,030.70 2,695.90 1,443.40 1,317.90 1,300.90 1,545.60 604.30 Short Term Provisions 3,724.00 2,103.40 1,460.20 976.10 453.50 573.90 402.90 363.20 46.60 457.20 Total Liabilities 37,037.10 27,496.40 23,085.90 19,925.40 20,086.50 18,155.50 15,074.30 13,249.20 11,832.10 9,654.30 Net Block 4,202.10 4,369.40 4,184.10 4,335.90 4,112.00 4,109.00 3,932.50 2,680.20 2,352.00 2,154.80 Gross Block 8,899.60 8,677.40 7,999.80 7,685.80 7,009.10 6,564.20 6,152.30 4,515.70 3,896.30 3,720.50 Accumulated Depreciation 4,697.50 4,308.00 3,815.70 3,349.90 2,897.10 2,455.20 2,219.80 1,835.50 1,544.30 1,565.70 Non Current Assets 18,502.70 17,710.00 14,666.60 12,217.80 13,712.30 12,859.40 10,499.00 9,380.60 9,675.90 6,328.70 Capital Work in Progress 1,188.50 633.90 739.30 384.00 570.50 552.60 674.90 659.20 678.40 296.80 Non Current Investment 7,255.00 7,283.00 4,677.70 4,897.50 6,470.60 6,404.10 4,190.50 3,618.10 3,923.70 2,216.60 Long Term Loans & Adv. 5,848.20 5,415.30 4,626.00 2,424.60 2,398.10 1,605.00 1,558.90 2,306.90 2,502.70 1,491.00 Other Non Current Assets 8.90 8.40 439.50 175.80 161.10 188.70 142.20 116.20 219.10 169.50 Current Assets 18,534.40 9,761.90 8,419.30 7,707.60 6,374.20 5,296.10 4,575.30 3,862.60 2,156.20 3,325.60 Current Investments 4,236.50 0.00 201.60 220.50 0.00 0.00 4.70 0.00 0.00 100.90 Inventories 1,952.10 1,687.30 1,782.40 1,926.30 1,780.00 1,394.70 1,472.50 1,320.70 932.90 657.50 Sundry Debtors 8,161.80 4,740.10 3,505.30 2,277.70 1,903.80 2,456.70 2,112.10 1,255.10 929.00 1,707.30 Cash & Bank 144.10 414.40 248.10 302.60 154.00 385.30 112.10 183.80 16.80 163.70 Other Current Assets 4,039.90 563.50 178.50 194.40 2,536.40 1,059.40 873.90 1,103.00 277.50 696.20 Short Term Loans & Adv. 3,639.50 2,356.60 2,503.40 2,786.10 2,269.70 896.70 594.10 670.40 237.00 597.40 Net Current Assets 7,463.30 5,369.90 4,368.10 2,809.50 1,210.70 1,343.40 1,456.10 760.70 -874.50 1,001.30 Total Assets 37,037.10 27,471.90 23,085.90 19,925.40 20,086.50 18,155.50 15,074.30 13,243.20 11,832.10 9,654.30

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 23,953.10 19,829.50 17,515.80 16,999.60 12,992.30 10,375.70 10,386.30 8,744.50 6,960.00 5,699.20 Share Capital 100.60 100.60 101.20 102.40 102.40 102.40 102.40 102.40 102.40 102.40 Total Reserves 23,852.50 19,728.90 17,414.60 16,897.20 12,889.90 10,273.30 10,283.90 8,642.10 6,857.60 5,596.80 Non-Current Liabilities -542.10 193.10 -725.00 -193.60 19.40 2,853.90 3,491.10 2,122.20 1,903.30 736.10 Secured Loans 0.00 0.00 0.00 0.00 0.00 1,953.60 2,332.80 200.60 319.60 393.80 Unsecured Loans 0.00 0.00 0.00 362.10 609.50 1,261.00 1,616.90 2,354.50 2,148.80 502.60 Long Term Provisions 383.90 309.70 271.80 325.00 309.50 235.20 184.10 155.90 151.20 120.70 Current Liabilities 9,041.60 5,339.70 5,526.70 7,826.80 7,861.30 8,269.40 7,342.50 6,072.00 5,305.80 3,461.00 Trade Payables 2,305.80 2,126.70 2,125.00 2,137.80 2,205.90 2,044.30 1,922.60 1,888.40 1,547.90 1,308.10 Other Current Liabilities 2,499.20 1,677.60 1,798.50 1,967.50 2,166.20 2,126.30 2,033.60 1,473.90 1,212.10 860.70 Short Term Borrowings 3,169.50 768.60 1,081.00 3,314.10 3,070.90 3,826.50 3,196.90 2,557.50 2,476.90 1,210.90 Short Term Provisions 1,067.10 766.80 522.20 407.40 418.30 272.30 189.40 152.20 68.90 81.30 Total Liabilities 34,857.90 27,634.40 24,490.00 26,687.00 22,810.30 22,833.70 22,512.80 17,129.70 14,325.20 10,032.10 Net Block 13,133.70 12,368.50 11,520.90 12,188.50 12,132.80 12,230.50 12,163.70 6,482.60 5,755.10 3,747.90 Gross Block 21,699.80 19,919.80 18,343.80 17,650.90 17,345.00 16,781.50 15,702.30 9,349.10 8,102.90 5,767.30 Accumulated Depreciation 8,566.10 7,551.30 6,822.90 5,462.40 5,212.20 4,551.00 3,538.60 2,866.50 2,345.80 2,016.80 Non Current Assets 17,811.80 16,135.20 14,477.60 14,438.20 14,094.30 14,118.30 14,014.70 8,911.00 8,302.90 5,751.70 Capital Work in Progress 2,691.90 2,423.30 1,200.70 725.90 783.20 741.50 837.20 1,527.20 1,543.30 950.80 Non Current Investment 1,556.70 968.00 927.30 934.80 631.20 552.20 443.60 470.90 385.70 217.10 Long Term Loans & Adv. 400.10 344.50 358.70 369.30 323.30 332.00 410.40 300.00 384.70 661.20 Other Non Current Assets 29.40 30.90 470.00 219.70 223.80 262.10 159.80 130.30 234.10 174.70 Current Assets 17,046.10 11,419.80 10,008.20 12,095.20 8,716.00 8,715.40 8,498.10 8,200.50 6,022.30 4,280.40 Current Investments 4,851.10 252.50 619.30 2,353.20 198.90 212.80 229.90 274.80 49.10 199.10 Inventories 3,944.00 3,441.90 3,413.30 3,719.40 3,236.20 2,789.00 2,688.00 2,385.30 1,803.70 1,337.10 Sundry Debtors 4,024.70 5,220.20 4,416.80 3,340.30 3,127.30 3,663.20 3,950.80 3,206.30 2,277.50 1,746.60 Cash & Bank 2,956.80 1,105.10 573.10 1,106.90 888.30 964.90 548.90 1,314.90 1,543.50 638.70 Other Current Assets 1,269.50 664.20 274.00 229.90 1,265.30 1,085.50 1,080.50 1,019.20 348.50 358.90 Short Term Loans & Adv. 717.30 735.90 711.70 1,345.50 1,003.00 874.50 806.10 730.10 268.50 234.80 Net Current Assets 8,004.50 6,080.10 4,481.50 4,268.40 854.70 446.00 1,155.60 2,128.50 716.50 819.40 Total Assets 34,857.90 27,555.00 24,485.80 26,533.40 22,810.30 22,833.70 22,512.80 17,111.50 14,325.20 10,032.10

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 3,114.00 2,000.30 1,078.20 1,272.20 2,227.20 1,180.60 580.70 287.70 867.10 1,954.00 PBT 7,444.70 4,239.80 2,032.20 1,163.90 1,688.50 1,625.90 1,796.50 1,497.20 642.20 2,503.80 Adjustment 325.10 -149.00 475.10 761.10 611.40 100.70 -51.70 199.70 -337.10 145.80 Changes in Working Capital -3,307.70 -1,192.80 -1,035.90 -382.80 191.10 -344.80 -852.00 -1,114.20 669.80 -279.40 Cash after chg. in Working capital 4,462.10 2,898.00 1,471.40 1,542.20 2,491.00 1,381.80 892.80 582.70 974.90 2,370.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1,348.10 -897.70 -393.20 -270.00 -263.80 -201.80 -312.20 -295.20 -111.80 -414.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.60 0.10 0.20 4.00 -1.70 Cash From Investing Activity -4,503.60 -1,831.80 -1,959.30 586.20 -2,713.80 55.00 -745.20 28.00 -2,479.70 -1,016.40 Net Fixed Assets -776.80 -572.20 -669.30 -490.20 -462.80 -289.60 -1,652.30 -600.20 -557.40 -531.50 Net Investments -4,208.50 -2,403.70 238.70 1,352.60 -66.50 -2,208.90 -577.10 305.60 -1,606.20 -108.40 Others 481.70 1,144.10 -1,528.70 -276.20 -2,184.50 2,553.50 1,484.20 322.60 -316.10 -376.50 Cash from Financing Activity 1,384.50 -300.80 827.00 -1,709.80 255.30 -966.70 64.90 -148.70 1,365.60 -923.30 Net Cash Inflow / Outflow -5.10 -132.30 -54.10 148.60 -231.30 268.90 -99.60 167.00 -247.00 14.30 Opening Cash & Equivalents 108.10 240.40 294.50 154.00 385.30 116.80 183.80 16.80 263.80 249.50 Closing Cash & Equivalent 103.00 108.10 240.40 302.60 154.00 385.30 116.80 183.80 16.80 263.80

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 6,776.70 3,196.30 2,688.80 2,104.50 3,293.90 2,931.50 1,281.90 919.30 1,311.70 1,893.50 PBT 6,026.70 4,838.10 2,582.70 5,232.30 2,284.80 1,495.40 2,382.10 2,312.00 1,611.90 2,098.70 Adjustment 1,020.40 546.70 933.90 -2,117.20 1,163.00 1,474.40 539.10 624.30 333.70 249.80 Changes in Working Capital 1,531.50 -902.70 -235.80 -336.00 191.10 263.80 -971.70 -1,383.90 -411.20 271.70 Cash after chg. in Working capital 8,578.60 4,482.10 3,280.80 2,779.10 3,638.90 3,233.60 1,949.50 1,552.40 1,534.40 2,620.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1,801.90 -1,285.80 -592.00 -674.60 -345.00 -302.50 -675.40 -602.30 -237.60 -646.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.40 7.80 -30.80 14.90 -80.70 Cash From Investing Activity -8,372.30 -1,475.20 1,535.00 -1,000.30 -724.60 -1,012.30 -4,238.70 -973.70 -2,871.90 -863.50 Net Fixed Assets -776.80 -572.20 -669.30 -490.20 -462.80 -289.60 -1,652.30 -600.20 -557.40 -531.50 Net Investments -4,208.50 -2,403.70 238.70 1,352.60 -66.50 -2,208.90 -577.10 305.60 -1,606.20 -108.40 Others -3,387.00 1,500.70 1,965.60 -1,862.70 -195.30 1,486.20 -2,009.30 -679.10 -708.30 -223.60 Cash from Financing Activity 2,014.20 -1,778.80 -4,400.40 -868.30 -2,547.70 -1,528.20 1,884.60 51.50 2,315.80 -934.80 Net Cash Inflow / Outflow 418.60 -57.70 -176.60 235.90 21.60 391.00 -1,072.20 -2.90 755.60 95.20 Opening Cash & Equivalents 413.00 487.80 657.80 888.30 1,177.70 778.80 1,589.70 1,592.60 837.00 737.90 Closing Cash & Equivalent 826.80 413.00 487.80 1,106.90 1,087.20 1,177.70 778.80 1,589.70 1,592.60 837.00

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 210.64 156.23 134.78 129.30 124.46 109.96 83.68 75.64 64.63 61.29 ROA 17.90% 13.61% 7.11% 4.29% 8.06% 8.94% 10.49% 8.70% 6.16% 23.55% ROE 31.29% 23.45% 11.38% 6.60% 12.30% 14.25% 18.21% 15.19% 10.27% 37.73% ROCE 30.86% 22.95% 13.45% 7.98% 11.13% 13.72% 16.58% 15.47% 7.85% 37.56% Fixed Asset Turnover 1.72 1.30 1.11 1.07 1.15 1.08 1.23 1.38 0.86 2.08 Receivable days 155.63 139.01 121.00 97.23 101.96 121.73 93.86 68.46 146.93 70.75 Inventory Days 43.90 58.49 77.60 86.18 74.23 76.39 77.86 70.64 88.64 37.42 Payable days 174.26 151.85 148.14 162.08 182.09 58.71 60.12 77.55 121.63 66.48 Cash Conversion Cycle 25.27 45.65 50.46 21.33 -5.89 139.41 111.59 61.54 113.94 41.69 Total Debt/Equity 0.39 0.39 0.35 0.20 0.31 0.33 0.42 0.37 0.44 0.19 Interest Cover 16.22 11.85 8.30 9.63 24.82 7.95 20.59 24.43 24.87 95.48

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 238.10 197.11 173.08 166.01 126.88 101.33 101.43 85.40 67.97 55.66 ROA 14.77% 14.70% 7.82% 9.40% 9.66% 5.18% 9.34% 11.11% 12.18% 20.14% ROE 21.08% 20.52% 11.60% 15.51% 18.88% 11.32% 19.36% 22.26% 23.43% 38.62% ROCE 26.06% 24.90% 13.64% 15.30% 14.23% 10.02% 15.89% 18.41% 16.50% 28.60% Fixed Asset Turnover 2.20 1.98 1.88 1.69 1.69 0.88 1.05 1.38 1.38 1.76 Receivable days 36.93 46.37 41.75 39.94 42.92 97.49 99.21 83.37 76.72 63.29 Inventory Days 29.51 32.98 38.39 42.95 38.08 70.13 70.33 63.69 59.88 54.52 Payable days 151.33 147.51 145.80 166.64 189.45 64.85 68.81 68.11 74.18 65.30 Cash Conversion Cycle -84.89 -68.16 -65.67 -83.76 -108.45 102.77 100.73 78.94 62.42 52.51 Total Debt/Equity 0.13 0.04 0.07 0.25 0.35 0.77 0.76 0.62 0.75 0.43 Interest Cover 32.55 60.22 20.94 23.35 16.11 5.38 13.17 21.87 26.55 40.75

Top Investors:

life insurance corporation of india

parag parikh flexi cap fund

kotak flexicap fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Zydus Lifesciences completes $166 million Assertio acquisition
17th Jun 2026, 16:45 PM

Assertio has become a wholly owned subsidiary of the company
Read More
Zydus Lifesciences - Quarterly Results
20th May 2026, 00:00 AM

Read More
Zydus Lifesciences reports 9% rise in Q4 consolidated net profit
19th May 2026, 16:00 PM

Consolidated total income of the company increased by 16.84% at Rs 7,721.20 crore for Q4FY26
Read More
Zydus Lifesciences’ arm inks definitive pact to acquire outstanding shares of Assertio
14th May 2026, 10:11 AM

The acquisition is expected to be completed in the financial year 2026-27 subject to customary conditions
Read More
USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility
6th May 2026, 13:06 PM

The inspection closed with seven observations
Read More
Zydus Lifesciences’ arm acquires 100% stake in FBC Medical
2nd May 2026, 10:57 AM

The acquisition is intended to internalize commercial capabilities currently outsourced to third-party sales agents
Read More
Zydus Lifesciences incorporates wholly owned subsidiary
30th Apr 2026, 14:41 PM

The company has incorporated a wholly owned subsidiary in the name of Zara Merger SUB Inc.
Read More
Zydus Lifesciences gets DCGI’s approval to initiate Phase III trials of Zintrodiazine
25th Apr 2026, 17:12 PM

The first Phase III clinical trial will be conducted in 651 patients with uncomplicated malaria due to P. falciparum
Read More
Zydus Lifesciences gets USFDA’s EIR, nod for oncology injectable facility in Ahmedabad
16th Apr 2026, 15:18 PM

The inspection was conducted from November 04, 2025 to November 13, 2025
Read More
Zydus Lifesciences gets USFDA’s approval for ‘Dapagliflozin Tablets’
8th Apr 2026, 11:08 AM

The company is eligible for 180 days of shared generic drug exclusivity for Dapagliflozin Tablets, 5 mg and 10 mg
Read More
Zydus Lifesciences launches Semaglutide Injection
21st Mar 2026, 13:12 PM

The company’s Semaglutide injection will be available in 15mg/3ml cartridge and will be manufactured at the company’s Biotech Park, Ahmedabad
Read More

Zydus Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532321 | NSE: ZYDUSLIFE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Zydus Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532321 | NSE: ZYDUSLIFE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: